News

NeuroVive Pharmaceutical CEO Mikael Brönnegård said that the partnership with Isomerase Therapeutics for the molecules recently acquired from Biotica marks the beginning of expansion of its product range.

Approved after conducting a priority review, XGEVA becomes the first FDA-passed treatment for this rare disease that cannot be taken away through surgery or planned surgical resection may

Under the terms of the agreement, BD’s BD Biosciences Custom Technology Team will perform sample analysis on Amarantus’ LymPro Test for Alzheimer’s disease. Amarantus president and CEO Gerald

The FDA approved the drug on December 14, 2012 for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant

Around $35m is likely to be invested to expand the 100,000ft2 facility by almost 80,000ft2 of manufacturing space. Expected to create as many as 90 new jobs, the

This collaboration focuses on the pairing of D. E. Shaw Research’s capabilities for conducting long-timescale molecular dynamics simulations with Zealand’s established in-house expertise in peptide drug innovation and

Orencia was developed to treat rheumatoid arthritis and already exists in the markets of US, Europe and Japan. As per the agreement, Simcere will carry out and fund

The new Tribrid architecture provides unprecedented depth of analysis of complex biological samples. Orbitrap Fusion LC-MS is a configuration of three different mass analyzers that work together to

Containing high concentration of the supplementary essential fatty acids EPA and DHA, the Omega-3 Unit Dose comes in a blister-format packaging and is pre-barcoded to help manage formulary